… (RCTs) that investigated the clinical efficacy of anti-viral agents for non-hospitalized patients
with COVID-19 were included. Three RCTs involving 4241 patients were included. Overall, …

… patients, reported that the early addition of molnupiravir to usual care did not reduce the
likelihood of hospital … the clinical efficacy of molnupiravir in treating patients with COVID-19. …

… azithromycin therapy for hospitalized patients with CAP is equal in efficacy to a 1993 ATS-suggested
regimen of cefuroxime with the addition of erythromycin when clinicians believe that …

… Umifenovir treatment did not shorten the negativity time of SARS-CoV-2, or the length of
hospital stay in non-ICU hospitalized patients with COVID-19. Since Umifenovir showed lower …

… This study compares the clinical efficacy of pulse flow and continuous flow oxygen in 100
patients recently hospitalized for diseases requiring O 2 therapy. In an unblinded crossover …

… The primary objective of the study is to avoid further clinical decline by administering
convalescent plasma to hospitalized patients early after symptom onset to provide immediate (…

… A number of studies found that no evidence of a strong antiviral activity or clinical benefit
of hydroxychloroquine for the treatment of our hospitalized patients with severe COVID-19 …

… of hospitalized patients with COVID-19 reduced mortality in matched-control studies, 9 -12
randomized clinical … not others, 14 -19 despite showing signals of efficacy in some subgroups. …

… the efficacy of sarilumab in hospitalized patients with severe/critical COVID-19. Post hoc
analyses were consistent with other studies that found a benefit of sarilumab in patients …

… hospital from February 19, 2020 to April 15, 2020, received 12,870 patients of which 2,968
were hospitalized … the total number of patients and 8.06 % among hospitalized patients [24]. …